Average Co-Inventor Count = 4.84
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (38 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (6 from 2,405 patents)
3. Pharmacopeia Drug Discovery, Inc. (4 from 52 patents)
4. Pharmacopeia Inc. (3 from 101 patents)
5. Schering-plough Corporation (1 from 28 patents)
6. Pharacopeia Drug Discovery, Inc. (1 from 1 patent)
7. Magatti, Charles V. (0 patent)
8. Doll, Ronald J. (0 patent)
9. Gold, Elijah H. (0 patent)
10. Neustadt, Bernard R. (0 patent)
11. Smith, Elizabeth M. (0 patent)
45 patents:
1. 10696639 - Heterocyclic compounds as HIV protease inhibitors
2. 8829036 - Heterocyclic aspartyl protease inhibitors
3. 8778980 - Heterocyclic aspartyl protease inhibitors
4. 8691833 - Heterocyclic aspartyl protease inhibitors
5. 8691831 - Heterocyclic aspartyl protease inhibitors
6. 8685967 - Substituted triazolopyridines and analogs thereof
7. 8242112 - Heterocyclic aspartyl protease inhibitors
8. 8178513 - Heterocyclic aspartyl protease inhibitors
9. 8114879 - Piperazine derivatives useful as CCR5 antagonists
10. 8110682 - Preparation and use of compounds as aspartyl protease inhibitors
11. 7973067 - Heterocyclic aspartyl protease inhibitors
12. 7884080 - Azetidinone derivatives and methods of use thereof
13. 7763609 - Heterocyclic aspartyl protease inhibitors
14. 7759354 - Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
15. 7700603 - Heterocyclic aspartyl protease inhibitors